(Total Views: 803)
Posted On: 03/06/2020 7:38:57 AM
Post# of 153905
Re: Girltrader #20335
Vyrologix
Word mark: VYROLOGIX
Status/Status Date:
PUBLISHED FOR OPPOSITION
2/25/2020
Serial Number: 88646441
Filing Date: 10/8/2019
Foreign Filing Deadline: Wednesday, April 8, 2020
Register a Trademark Internationally
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 2/25/2020
Last Applicant/Owner: CytoDyn Inc.
Vancouver, WA 98660
Why is this contact information displayed?
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
JARED M. BARRETT
SEED IP LAW GROUP LLP
701 FIFTH AVENUE
SUITE 5400
SEATTLE, WA 98104
Classification Information
Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.
Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Word mark: VYROLOGIX
Status/Status Date:
PUBLISHED FOR OPPOSITION
2/25/2020
Serial Number: 88646441
Filing Date: 10/8/2019
Foreign Filing Deadline: Wednesday, April 8, 2020
Register a Trademark Internationally
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 2/25/2020
Last Applicant/Owner: CytoDyn Inc.
Vancouver, WA 98660
Why is this contact information displayed?
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
JARED M. BARRETT
SEED IP LAW GROUP LLP
701 FIFTH AVENUE
SUITE 5400
SEATTLE, WA 98104
Classification Information
Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.
Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
(7)
(0)
